GENIXUS Revenue and Competitors

Acute and critical care medicines help hospital staff save countless lives while under enormous pressure. Yet the space has seen precious little innovation for decades, leaving hospitals and patients at the mercy of outdated technologies. GENIXUS began in 2019 shortly after our founder visited the ICU with his two-week-old daughter and observed injections being administered with hand-written syringes. It seemed out of place in modern medicine. How, for instance, did they track the syringe? How could they be sure what was in it? And could quality be maintained? From his long experience in pharmaceutical and vaccine manufacturing, he knew there had to be a better way. The idea for GENIXUS was born: create a platform that brings together the brightest minds and latest innovations to reinvent how acute and critical care medicines are manufactured and delivered. Safeguarding what matters by bringing critical thinking to critical care.